Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06577636 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Induction of Dreaming With EEG and Anesthesia for Post-traumatic Stress Disorder

Study acronym: IDEA_PTSD
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Dec 2026 → Dec 2028
See other at-risk trials from Stanford University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 2026 to Dec 2028 Show 7 more changesShow less
    • Study completion pushed from Dec 2026 to May 2029
    • Interventions modified
    • Eligibility criteria expanded, about 190 words
    • Secondary endpoints: 3 to 4
    • Study description expanded, about 33 words
    • Collaborators: 1 to 2
    • Publications: 3 to 5
  2. Re-verified, no change to tracked fieldsv4
  3. Trial status: Not Yet Recruiting to Recruitingv3 Show 6 more changesShow less
    • Start date changed from estimate of Dec 2024 to Jul 21, 2025
    • Eligibility criteria revised
    • Secondary endpoints: details revised at 2 of 3 entries
    • Study description expanded, about 128 words
    • Site details revised
    • Study arms: 2 to 3
  4. Primary endpoint revisedv2 Show 4 more changesShow less
    • Eligibility criteria shortened, about 650 words
    • Secondary endpoints revised (3)
    • Study description shortened, about 19 words
    • Publications: 2 to 3
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Stanford University
634 trials monitored
See 47 trials at risk
PTSD
889 trials monitored
See 54 trials at risk
The goal of this study is to test whether anesthesia-induced experiences can help alleviate symptoms of PTSD in an (1) open-label trial (Phase I) and (2) single-center double-blind, randomized, active-comparator (dose-controlled) participant-and assessor-blinded Phase 2 clinical trial (Phase II) in a non-surgical setting. Participants will undergo EEG-guided propofol anesthesia during which they will be either (1) receiving a sedation protocol associated with dream experiences upon emergence (Dream Condition), and/or (2) a sedation protocol associated with non-dream experiences (Non-Dream Condition). The investigators will then investigate whether the Dream Condition is associated with a larger reduction in PTSD symptoms than the Non-Dream Condition.
Trial Details
NCT Number NCT06577636
Lead Sponsor Stanford University
Collaborators: Tiny Blue Dot Foundation, Advanced Research Projects Agency for Health (ARPA-H)
Conditions
(from sponsor)		 PTSD, Post-traumatic Stress Disorder
Related terms Stress Disorders, Post-Traumatic
Enrollment 42 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov